Uganda Declares End to Sixth Ebola Outbreak

Uganda has officially declared the conclusion of its sixth Ebola virus outbreak, marking a significant milestone in the nation's health response. The outbreak, which began in late January, resulted in the death of at least two individuals and affected a total of 14 reported cases—12 confirmed and two probable—according to the World Health Organization (WHO). The confirmed cases involved the Sudan Ebola strain, including the death of a young child and a nurse. Throughout the outbreak, dozens of contacts were monitored to prevent further transmission.
The WHO reported that the outbreak was brought under control after 42 days had passed without any new confirmed cases, with the last patient being discharged on March 14, 2025. Uganda’s health authorities praised their team and the community for their effective response, facilitated in part by a rapid vaccination trial launched in February for the strain involved. This trial was notable as one of the fastest Ebola vaccine rollouts ever conducted during an ongoing epidemic.
The Ebola virus spreads primarily through contact with body fluids of infected individuals, with symptoms typically appearing after an incubation period of two to 21 days. While there is currently no approved vaccine for the Sudan strain, the ongoing vaccination efforts aim to contain future outbreaks.
The global health community continues to emphasize the importance of swift responses and adequate funding, especially as international aid has seen reductions following the US cessation of most humanitarian support. Past outbreaks have resulted in over 15,000 deaths in Africa across all six known Ebola strains.
World Health Organization Director Tedros Adhanom Ghebreyesus commended Uganda’s leadership and dedication in managing and ending this outbreak, underscoring the ongoing need for preparedness and international cooperation to combat Ebola.
Source: https://medicalxpress.com/news/2025-04-uganda-declares-6th-ebola-outbreak.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Promising Chemoimmunotherapy Approach for Aggressive Stage III Non-Small Cell Lung Cancer
A groundbreaking study suggests that combining chemotherapy with immunotherapy before surgery may improve outcomes for patients with aggressive stage III non-small cell lung cancer, potentially converting unresectable tumors into operable ones.
Persistent Use of Unnecessary Cancer Screenings Despite Updated Guidelines, New Study Reveals
A new study reveals that unnecessary cancer screenings persist for years after guidelines advise against them, leading to overdiagnosis and increased healthcare costs. The research emphasizes the need for better implementation of evidence-based practices.
Unraveling the Genetic Diversity of Glioblastoma Tumors
A groundbreaking study reveals the extensive genomic heterogeneity within glioblastoma tumors, highlighting the importance of targeting shared abnormalities for more effective treatments. Source: Northwestern University, 2025.
Smartphone Data Predicts Recovery Outcomes After Bone Fractures
Innovative study reveals how smartphone mobility data can predict recovery outcomes in patients with broken legs or hips, paving the way for personalized treatment plans.